Releasing agent: Difference between revisions

Line 1:

A '''releasing agent''' is a drug that induces the transfer of a [[neurotransmitter]] from the presynaptic [[neurone]] into the synapse, leading to elevated extracellular concentrations of the neurotransmitter, therefore resulting increased neurotransmission. Many drugs use neurotransmitter release to exert their psychological and physiological effects, ~~namely the~~ [[amphetamines]] and ~~related compounds~~. Virtually all currently known releasing agents affect the monoamine neurotransmitters [[serotonin]], [[noradrenaline]], and/or [[dopamine]], and as such, they are often referred to more formally as monoamine releasing agents (MRAs). MRAs, like [[agonists]] may be selective for a particular neurotransmitter or non-selective and affect multiple neurotransmitters.

A '''releasing agent''' is a drug that induces the transfer of a [[neurotransmitter]] from the presynaptic [[neurone]] into the synapse, leading to elevated extracellular concentrations of the neurotransmitter, therefore resulting increased neurotransmission. Many drugs use neurotransmitter release to exert their psychological and physiological effects, including [[amphetamines]], [[cathinones]], and [[tryptamines]]. Virtually all currently known releasing agents affect the monoamine neurotransmitters [[serotonin]], [[noradrenaline]], and/or [[dopamine]], and as such, they are often referred to more formally as monoamine releasing agents (MRAs). MRAs, like [[agonists]] may be selective for a particular neurotransmitter or non-selective and affect multiple neurotransmitters.

==Mechanism of Action==

Revision as of 01:46, 7 September 2016 view source >Kaylee No edit summary ← Older edit		Revision as of 01:51, 7 September 2016 view source >Kaylee No edit summary Newer edit →
Line 1:		Line 1:
	A '''releasing agent''' is a drug that induces the transfer of a [[neurotransmitter]] from the presynaptic [[neurone]] into the synapse, leading to elevated extracellular concentrations of the neurotransmitter, therefore resulting increased neurotransmission. Many drugs use neurotransmitter release to exert their psychological and physiological effects, ~~namely the~~ [[amphetamines]] and ~~related compounds~~. Virtually all currently known releasing agents affect the monoamine neurotransmitters [[serotonin]], [[noradrenaline]], and/or [[dopamine]], and as such, they are often referred to more formally as monoamine releasing agents (MRAs). MRAs, like [[agonists]] may be selective for a particular neurotransmitter or non-selective and affect multiple neurotransmitters.		A '''releasing agent''' is a drug that induces the transfer of a [[neurotransmitter]] from the presynaptic [[neurone]] into the synapse, leading to elevated extracellular concentrations of the neurotransmitter, therefore resulting increased neurotransmission. Many drugs use neurotransmitter release to exert their psychological and physiological effects, including [[amphetamines]], [[cathinones]], and [[tryptamines]]. Virtually all currently known releasing agents affect the monoamine neurotransmitters [[serotonin]], [[noradrenaline]], and/or [[dopamine]], and as such, they are often referred to more formally as monoamine releasing agents (MRAs). MRAs, like [[agonists]] may be selective for a particular neurotransmitter or non-selective and affect multiple neurotransmitters.

	==Mechanism of Action==		==Mechanism of Action==